Now Reading
Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities

Premium Content

Login to buy access to this content.

Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities

Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities
By Roger S. McIntyre, Danielle S. Cha

  • Hardcover: 370 pages
  • Publisher: Cambridge University Press; 1 edition (April 13, 2016)
  • Language: English
  • ISBN-10: 1107074584
  • ISBN-13: 978-1107074583
  • Major Depressive Disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principle determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described. This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD.

    Premium Content

    Login to buy access to this content.
    What's Your Reaction?
    Excited
    0
    Happy
    0
    In Love
    0
    Not Sure
    0
    Silly
    0

    © 2020 DownMedBook. All Rights Reserved.

    Scroll To Top